Biologic use in hidradenitis suppurativa: patient perspectives and barriers.
Devea R DeTerri ShihDenise FixsenBrindley BrooksJennifer L HsiaoVivian Y ShiPublished in: The Journal of dermatological treatment (2022)
Our results highlight the importance of specialty care in the education and implementation of biologics. Patients may benefit from comprehensive discussion prior to starting biologics.
Keyphrases
- healthcare
- quality improvement
- end stage renal disease
- hidradenitis suppurativa
- ejection fraction
- newly diagnosed
- rheumatoid arthritis
- chronic kidney disease
- primary care
- palliative care
- prognostic factors
- peritoneal dialysis
- case report
- patient reported outcomes
- pain management
- health insurance
- affordable care act